Effectiveness of serum beta-2 microglobulin as a tool for evaluating donor kidney status for transplantation

[1]  Daryl A Jones,et al.  Frequency and outcomes of kidney donation from intensive care patients with acute renal failure requiring renal replacement therapy , 2019, Nephrology.

[2]  C. Jung,et al.  Effectiveness of Thymoglobulin Induction Therapy in Kidney Transplant From Deceased Donor With Mild to Moderate Acute Kidney Injury. , 2019, Transplantation proceedings.

[3]  Colin H. Wilson,et al.  Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation. , 2019, The Cochrane database of systematic reviews.

[4]  T. Muthukumar,et al.  Deceased-donor acute kidney injury is not associated with kidney allograft failure. , 2019, Kidney international.

[5]  W. Irish,et al.  Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  Xiao-Peng Yuan,et al.  Impact of acute kidney injury in donors on renal graft survival: a systematic review and Meta-Analysis , 2018, Renal failure.

[7]  C. Jung,et al.  Clinical Outcomes in Kidney Transplantation from Deceased Donors with Acute Kidney Injury Based on Acute Kidney Injury Network Criteria. , 2018, Transplantation proceedings.

[8]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[9]  Xianlin Xu,et al.  Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis , 2018, Clinical and Experimental Nephrology.

[10]  Kamran Shaffi,et al.  Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases , 2017, Front. Med..

[11]  Joachim Frank,et al.  The mechanism of translation , 2017, F1000Research.

[12]  J. J. Homan van der Heide,et al.  Transplantation of Kidneys From Donors With Acute Kidney Injury: Friend or Foe? , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  G. Russo,et al.  Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes. , 2017, Journal of diabetes and its complications.

[14]  J. Farber,et al.  Correlation of acute tubular injury in reperfusion biopsy with renal transplant outcomes , 2016, Clinical transplantation.

[15]  Mahboob Rahman,et al.  Nephrology Update: End-Stage Renal Disease and Renal Replacement Therapy. , 2016, FP essentials.

[16]  S. Kim,et al.  Decision Making by Young Transplant Surgeons Regarding Expanded-Criteria Donors With Acute Kidney Injury or Allocation Failure. , 2016, Transplantation proceedings.

[17]  S. Kim,et al.  Epidemiology of Kidney Discard from Expanded Criteria Donors Undergoing Donation after Circulatory Death. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[18]  Rachel J. Johnson,et al.  Kidney donation after circulatory death (DCD): state of the art. , 2015, Kidney international.

[19]  D. Salomon,et al.  Transplanting Kidneys from Deceased Donors With Severe Acute Kidney Injury , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  X. Jouven,et al.  Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study , 2015, BMJ : British Medical Journal.

[21]  M. Shoukri,et al.  Outcomes of kidneys utilized from deceased donors with severe acute kidney injury. , 2015, QJM : monthly journal of the Association of Physicians.

[22]  Jing-he Li,et al.  ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer , 2015, Journal of Molecular Histology.

[23]  Jing-he Li,et al.  ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer , 2014, Journal of Molecular Histology.

[24]  C. Suh,et al.  Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor , 2014, Blood research.

[25]  Bülent Yılmaz,et al.  Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease. , 2014, World journal of gastroenterology.

[26]  C. Legendre,et al.  Delayed kidney graft function: from mechanism to translation. , 2014, Kidney international.

[27]  Bernard Jaar,et al.  Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  H. Tedesco-Silva,et al.  Transplantation With Kidneys Retrieved From Deceased Donors With Acute Renal Failure , 2013, Transplantation.

[29]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[30]  D. Brennan,et al.  Delayed Graft Function in the Kidney Transplant , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  E. Fung,et al.  Proteomic biomarkers for overall and progression‐free survival in ovarian cancer patients , 2010, Proteomics. Clinical applications.

[32]  M. Schnitzler,et al.  A Risk Prediction Model for Delayed Graft Function in the Current Era of Deceased Donor Renal Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  J. Kellum,et al.  Preload responsiveness is associated with increased interleukin-6 and lower organ yield from brain-dead donors* , 2009, Critical care medicine.

[34]  R. Formica,et al.  Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  X. Mariette,et al.  Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity , 2008, Annals of the rheumatic diseases.

[36]  G. Rakhorst,et al.  Early Events in Kidney Donation: Progression of Endothelial Activation, Oxidative Stress and Tubular Injury After Brain Death , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[37]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[38]  Markus Voelter,et al.  State of the Art , 1997, Pediatric Research.

[39]  L. W. Statius van Eps,et al.  β2-microglobulin: Its significance in the evaluation of renal function , 1987 .